Published in Vaccine Weekly, July 26th, 2006
Two of these vaccine candidates will target causes of pediatric respiratory disease in the United States: human respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (PIV-3). Additionally, MedImmune has started vaccinating patients in a second phase 1 study with MEDI-534, the company's own...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly